Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01952041 · ClinicalTrials.gov registry record · NA

A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia

A NA study of Schizophrenia and Schizoaffective Disorder, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
149
Enrollment target
1
Study location

NCT01952041 is a NA study of Schizophrenia and Schizoaffective Disorder that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 149 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01952041, a NA study of Schizophrenia and Schizoaffective Disorder, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
149 participants
Enrollment target
1
Study location

Study Summary

This study was a 2-arm randomized control trial (RCT) designed to test a multi-modal smartphone data collection system that provided mobile monitoring of schizophrenia to detect early signs of relapse. The RCT compared an arm with participants who received treatment as usual with an arm that received the smartphone system for a year.

Conditions Studied

Schizophrenia Schizoaffective Disorder

Interventions

  • BEHAVIORAL Treatment as usual
  • BEHAVIORAL Device: Smartphone

Study Locations (1)

New York

  • Zucker Hillside Hospital - Glen Oaks

Trial Details

FieldValue
Enrollment Target 149 participants
Start Date 2015-03-13
Est. Completion 2017-08-07
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01952041

The ClinicalTrials.gov registry entry for NCT01952041 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (32% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.

NCT01952041 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01952041 about?

NCT01952041 is a clinical study titled "A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia". This study was a 2-arm randomized control trial (RCT) designed to test a multi-modal smartphone data collection system that provided mobile monitoring of schizophrenia to detect early signs of relapse. The RCT compared an arm with participants who received treatment as usual with an arm that receive...

What is the current status of trial NCT01952041?

This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2015-03-13. Estimated completion is 2017-08-07.

What conditions does trial NCT01952041 study?

This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.

What interventions are being tested in trial NCT01952041?

The interventions under investigation include: Treatment as usual (BEHAVIORAL), Device: Smartphone (BEHAVIORAL).

Who is sponsoring clinical trial NCT01952041?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01952041 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Schizophrenia

All registered trials for this condition

Schizoaffective Disorder

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.